Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LimmaTech Biotechnologies
Biotech
Valneva pays LimmaTech $10M for clinical-stage Shigella vaccine
Valenva added to its growing arsenal of vaccines by handing over 10 million euros for a Shigella candidate that once formed part of a GSK partnership.
James Waldron
Aug 1, 2024 8:26am
Stanford president resigns—Chutes & Ladders
Jul 21, 2023 9:30am
LimmaTech regains shigella shot from GSK, new CEO from CureVac
Jul 20, 2023 10:31am
